Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of Urology
|
January 5, 2021
Editorial Comment
Martin Gelbard
Urology
|
June 15, 2016
Editorial Comment
Martin Gelbard
The Journal of Sexual Medicine
|
December 19, 2008
Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie's disease?
Martin Gelbard
The Journal of Sexual Medicine
|
November 1, 2007
RE: graft materials in Peyronie's disease surgery: a comprehensive review by Ates Kadioglu, MD, Oner Sanli, MD, et al. J Sex Med 2007;4:581-95
Martin Gelbard
The Journal of Urology
|
April 17, 2012
Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease
Martin Gelbard, Larry I Lipshultz, James Tursi, et al.
The Journal of Sexual Medicine
|
October 12, 2013
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease
Martin Gelbard, Wayne J G Hellstrom, Chris G McMahon, et al.
The Journal of Urology
|
January 24, 2019
Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis
Wayne J G Hellstrom, Hoang Minh Tue Nguyen, Laith Alzweri, et al.
Urology
|
August 11, 2020
Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis
Hoang Minh Tue Nguyen, Ayad Yousif, Amanda Chung, et al.
The Journal of Urology
|
February 5, 2013
Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies
Martin Gelbard, Irwin Goldstein, Wayne J G Hellstrom, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of Urology
|
January 5, 2021
Editorial Comment
Martin Gelbard
Urology
|
June 15, 2016
Editorial Comment
Martin Gelbard
The Journal of Sexual Medicine
|
December 19, 2008
Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie's disease?
Martin Gelbard
The Journal of Sexual Medicine
|
November 1, 2007
RE: graft materials in Peyronie's disease surgery: a comprehensive review by Ates Kadioglu, MD, Oner Sanli, MD, et al. J Sex Med 2007;4:581-95
Martin Gelbard
The Journal of Urology
|
April 17, 2012
Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease
Martin Gelbard, Larry I Lipshultz, James Tursi, et al.
The Journal of Sexual Medicine
|
October 12, 2013
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease
Martin Gelbard, Wayne J G Hellstrom, Chris G McMahon, et al.
The Journal of Urology
|
January 24, 2019
Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis
Wayne J G Hellstrom, Hoang Minh Tue Nguyen, Laith Alzweri, et al.
Urology
|
August 11, 2020
Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis
Hoang Minh Tue Nguyen, Ayad Yousif, Amanda Chung, et al.
The Journal of Urology
|
February 5, 2013
Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies
Martin Gelbard, Irwin Goldstein, Wayne J G Hellstrom, et al.
Page
of 1